Shortage of Contrast for Imaging Services

Because of a global shortage of iodinated contrast material (Omnipaque) caused by temporary overseas manufacturing disruptions, ChristianaCare is taking steps to preserve supply so that it remains available for the most time-sensitive and urgent patient needs. (Learn more in our frequently asked questions.)

Omnipaque contrast is the most widely used contrast material for CT scans and radiographic examinations at ChristianaCare facilities. It is also used for cardiac imaging and interventions, and in the GI lab, Surgicenter and other settings.

The shortage is expected to last several weeks, and likely into the summer months.

Hospitals and health care organizations worldwide are managing the effects of the shortage and the impact to patient care.

ChristianaCare is making every effort to meet the needs of patients who need this product in their procedures. We are working individually with physicians to prioritize those patients with the most urgent needs.

Wherever possible, we are using alternative contrast material and limiting its use to ensure adequate supplies for time sensitive and emergent exams. It is possible that some elective procedures that use this product will need to be delayed.

ChristianaCare will continue to look for options to minimize disruptions created by the shortage, as we serve our community as expert, caring partners in health.

Learn more in our frequently asked questions (FAQs).

COVID-19: New Visitation Guidelines. Click here for what to expect at ChristianaCare during COVID-19.

ChristianaCare

Shortage of Contrast for Imaging Services

Because of a global shortage of iodinated contrast material (Omnipaque) caused by temporary overseas manufacturing disruptions, ChristianaCare is taking steps to preserve supply so that it remains available for the most time-sensitive and urgent patient needs. (Learn more in our frequently asked questions.)

Omnipaque contrast is the most widely used contrast material for CT scans and radiographic examinations at ChristianaCare facilities. It is also used for cardiac imaging and interventions, and in the GI lab, Surgicenter and other settings.

The shortage is expected to last several weeks, and likely into the summer months.

Hospitals and health care organizations worldwide are managing the effects of the shortage and the impact to patient care.

ChristianaCare is making every effort to meet the needs of patients who need this product in their procedures. We are working individually with physicians to prioritize those patients with the most urgent needs.

Wherever possible, we are using alternative contrast material and limiting its use to ensure adequate supplies for time sensitive and emergent exams. It is possible that some elective procedures that use this product will need to be delayed.

ChristianaCare will continue to look for options to minimize disruptions created by the shortage, as we serve our community as expert, caring partners in health.

Learn more in our frequently asked questions (FAQs).

COVID-19: New Visitation Guidelines. Click here for what to expect at ChristianaCare during COVID-19.

Center for Heart & Vascular Health

Left Ventricular Assist Device (LVAD), advanced technology for heart failure patients

Technological innovation is changing treatment for heart failure, and ChristianaCare has brought it closer to home.

There are only about 2,000 heart transplants a year in the United States. For those with heart failure who can’t get a transplant, there are few long-term options. One of those options is called LVAD, which stands for left-ventricular assist device.

ChristianaCare is the only health system in Delaware to offer LVAD, the most advanced treatment short of transplant for people with heart failure.

People with advanced heart failure have often reached their maximum doses of medications and may have undergone coronary bypass or valve operations. For patients, the LVAD can represent a bridge to heart transplantation, a bridge to recovery or a destination therapy if transplantation is not an option.

The battery-powered LVAD device is implanted during open heart surgery and replaces the pumping action of the heart. The latest LVAD is smaller, more durable and improves quality of life for patients in multiple ways.

At least one support person must learn how to take care of the device and the patient, and must join the patient for weekly hospital visits after the surgery.

LVAD benefits include:

ChristianaCare’s Left Ventricular Assist Device Program (LVAD) was launched in 2011. LVAD is part of a comprehensive Heart Failure Program at the Center for Heart & Vascular Health that allows patients to receive tests, medications, stress management, nutrition counseling and other high-quality care without having to leave the state.

The LVAD team is available to answer your questions. For more information contact the LVAD coordinator at 855-VAD-CCHS (855-823-2247). (Current LVAD patients should press option 1, to make an appointment with a heart failure physician press option 2, if you would like more information on the LVAD program, press option 3.)


Additional Resources

ChristianaCare Center for Heart & Vascular Health
Christiana Hospital
4755 Ogletown-Stanton Road, Newark, DE 19718 directions
302-733-1000